Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ahre

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Haematology|August 1, 1988
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS)A Ahre, M Björkholm, A Osterborg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central SwedenA Osterborg, A Ahre, M Björkholm, et al.
Cancer Treatment Reports|November 1, 1984
Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central SwedenA Ahre, M Björkholm, H Mellstedt, et al.
European Journal of Haematology|July 1, 1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCSA Osterborg, A Ahre, M Björkholm, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaA Ahre, M Björkholm, H Mellstedt, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Haematology|August 1, 1988
High doses of natural alpha-interferon (alpha-IFN) in the treatment of multiple myeloma--a pilot study from the Myeloma Group of Central Sweden (MGCS)A Ahre, M Björkholm, A Osterborg, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1990
Oral versus intravenous melphalan and prednisone treatment in multiple myeloma stage II. A randomized study from the Myeloma Group of Central SwedenA Osterborg, A Ahre, M Björkholm, et al.
Cancer Treatment Reports|November 1, 1984
Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central SwedenA Ahre, M Björkholm, H Mellstedt, et al.
European Journal of Haematology|July 1, 1989
Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCSA Osterborg, A Ahre, M Björkholm, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Intermittent high-dose melphalan/prednisone vs continuous low-dose melphalan treatment in multiple myelomaA Ahre, M Björkholm, H Mellstedt, et al.
Pageof 2